1386 Organometallics, Vol. 29, No. 6, 2010
Li et al.
cooling bath was removed and the reaction mixture was allowed
to slowly warm to ambient temperature, at which time it was
stirred for an additional 2 h. Afterward, a solution of azeotro-
pically predried iodoresorcinol (1 mmol, 0.236 g) and Et3N (2.2
mmol, 304 μL) in toluene (5 mL) was slowly added to the
reaction mixture, which was then heated to 110 °C for 1 h. After
cooling, a white salt was rapidly filtered off over a short plug of
Celite, and the filter cake was washed with toluene (2 ꢀ 5 mL).
The combined toluene fractions were concentrated under re-
duced pressure and were thoroughly dried under vacuum to
yield an off-white solid. 31P NMR spectra indicated that the
purity of the crude products was higher than 90%, so that they
were directly used in the next step without further purification.
Thereafter, the off-white solid was redissolved in toluene (20
6.88 (d, J=7.6 Hz, 2H, PhH), 6.94 (t, J=7.6 Hz, 2H, PhH), 7.07
(d, J=7.6 Hz, 2H, ArH), 7.12 (t, J=8 Hz, 2H, PhH), 7.22-7.25
(m, 1H, ArH). 13C{1H} NMR (CDCl3, 100.6 Hz): δ 34.0, 62.5,
75.6, 107.6 (t, J=10 Hz), 114.5, 123.7, 125.6, 128.0, 130.5, 132.0,
142.4 (t, J =6.64 Hz), 156.9 (t, J =10.8 Hz). 31P{1H} NMR
(CDCl3, 161.9 Hz): δ 150.2 (s). [R]20D -470 (c 0.1, CHCl3). MS
(MALDI-TOF): m/z calcd for C24H21N2O4P2Pd 569.00 [M -
I]þ, found 569.03. Anal. Calcd for C24H21IN2O4P2Pd: C, 41.37;
H, 3.04; N, 4.02; P, 8.89. Found: C, 41.41; H, 3.01; N, 3.98; P,
8.93.
General Procedure for P-Chiral Palladium Pincer Metal Com-
plex Catalyzed Allylation of Aldimines. Allyltributylstannane
(56 μL, 0.18 mmol) was added to a mixture of sulfonimine (0.15
mmol), pincer Pd complex 1 or 2 (0.0075 mmol), and dry DMF
(1 mL). The reaction mixture was then stirred for 96 h at room
temperature and was quenched by the addition of a saturated
aqueous KF solution (1 mL). The resulting mixture was vigir-
ously stirred at room temperature for another 24 h. The crude
product was extracted with EtOAc (3 ꢀ 2 mL), and the
combined organic layers were dried over MgSO4. Analytically
pure allylic product was obtained by purification on a silica gel
column (hexanes/EtOAc, 7:3 (v/v)). The enantiomeric excess
was determined by chiral-phase HPLC (Daicel Chiracel OD-H
or AS-H columns).
mL), and this solution was added to Pd2(dba)3 CHCl3 (0.9
3
mmol, 0.932 g) in toluene (10 mL). The reaction mixture was
stirred at ambient temperature overnight in the absence of light.
The crude reaction mixture was then concentrated under re-
duced pressure, and the title complex was purified by repeating
precipitation out of a small amount of CH2Cl2 by the addition of
hexanes. Alternatively, the complex was directly subjected to
chromatography by using predried silica gel and eluent (EtOAc/
hexanes, 3:7 (v/v)).
Spectral Data for Crude Product of Compound 3. Yield:
quantitative (0.805 g). 1H NMR (CDCl3, 400 MHz): δ 1.40
(m, 2H, CH2), 1.53 (m, 4H, CH2), 1.71 (m, 2H, CH2), 2.85
(apparent t, J=8.4 Hz, 2H, NCH2), 3.15 (m, 2H, NCH2), 4.11
(m, 2H, NCH), 6.18 (d, J=6.8 Hz, 2H, ArH), 6.85 (t, J=7.2 Hz,
1H, ArH), 7.20 (t, J=7.8 Hz, 4H, PhH), 7.22-7.38 (m, 8H,
PhH), 7.43 (d, J=6.4 Hz, 4H, PhH), 7.55 (d, J=7.2 Hz, 4H,
PhH). 13C{1H} NMR (CDCl3, 100.6 Hz): δ 24.8, 30.73, 47.9 (t,
J=9.0 Hz), 69.8, 94.5 (t, J=4.0 Hz), 105.8 (t, J=9.6 Hz), 125.5,
126.3, 127.8, 128.5, 128.9, 129.0, 129.2, 129.4, 129.7, 133.5, 139.4
(t, J=4.0 Hz), 143.9, 146.5. 31P{1H} NMR (CDCl3, 161.9 Hz): δ
141.1 (s).
N1-[1-(4-Nitrophenyl)-3-butenyl]-2,4,6-trimethyl-1-benze-
nesulfonamide, 15a. 1H NMR (CDCl3, 400 MHz): δ 2.21 (s, 3H,
Me), 2.43 (t, J=6.8 Hz, 2H, CH2CHdCH2), 2.48 (s, 6H, Me),
4.40 (q, J=7.2 Hz, 1H, CH=CH2), 5.08-5.12 (apparent t, 2H,
CHdCH2), 5.30 (br s, 1H, NH), 5.47-5.54 (m, 1H, ArCH-
(NH)), 6.78 (s, 2H, mesityleneH), 7.22 (d, J=8 Hz, 2H, ArH),
7.94 (d, J=8 Hz, 2H, ArH). 13C NMR (CDCl3, 100.6 MHz): δ
21.1, 23.2, 42.0, 56.7, 120.8, 123.6, 127.7, 132.0, 132.4, 133.9,
139.1, 143.0, 147.3, 148.1. Anal. Calcd for C19H22N2O4S: C,
60.94; H, 5.92; N, 7.48; S, 8.56. Found: C, 60.99; H, 5.88; N,
7.45; S, 8.51. The enantiomeric excess of 15a was determined by
chiral-phase HPLC (Daicel Chiracel AD, hexane/iPrOH, 9:1
(v/v), flow rate 1.0 mL/min): major enantiomer tR=13.4 min,
minor enantiomer tR=11.0 min.
Spectral Data for Complex 1. 1 was obtained as a light yellow
solid (0.497 g, 0.55 mmol). Yield: 55%. The single crystals were
grown by slow diffusion of diethyl ether into a solution of
1
CH2Cl2. H NMR (CDCl3, 400 MHz): δ 1.44 (m, 2H, CH2),
N1-[1-(4-Nitrophenyl)-3-butenyl]-2,4,6-triisopropyl-1-benzene-
sulfonamide, 16a. 1H NMR (CDCl3, 400 MHz): δ 1.13 (d, J=6.8
1.79 (m, 4H, CH2), 2.18 (m, 2H, CH2), 3.33 (apparent t, J=9.2
Hz, 2H, NCH2), 4.26 (m, 2H, NCH2), 4.79 (m, 2H, NCH), 6.26
(d, J=7.6 Hz, 2H, ArH), 6.93 (t, J=8.0 Hz, 1H, ArH), 7.26 (t, J=
8 Hz, 4H, PhH), 7.32-7.40 (m, 8H, PhH), 7.47 (d, J=7.2 Hz,
4H, PhH), 7.61 (d, J = 6.8 Hz, 4H, PhH). 13C{1H} NMR
(CDCl3, 100.6 Hz): δ 25.8, 30.7, 48.0 (t, J=9.6 Hz), 71.0, 94.4
(t, J=3.3 Hz), 106.8 (t, J=9.5 Hz), 126.5, 127.3, 127.8, 128.1,
128.3, 128.4, 128.6, 128.7, 129.7, 141.4 (t, J=3.7 Hz), 143.7,
157.1 (t, J=11 Hz). 31P{1H} NMR (CDCl3, 161.9 Hz): δ 160.3
(s). [R]20D -83, (c 0.1, CHCl3). MS (MALDI-TOF): m/z calcd
for C40H37N2O4P2Pd 777.13 [M - I]þ, found 777.11; Anal.
Calcd for C40H37IN2O4P2Pd: C, 53.09; H, 4.12; N, 3.10; P, 6.84.
Found: C, 53.12; H, 4.16; N, 3.07; P, 6.82.
Spectral Data for Crude Product of Compound 7. Yield:
quantitative (0.601 g). 1H NMR (CDCl3, 400 MHz): δ 3.10
(d, J=7.2 Hz, 1H, CH2), 3.14 (d, J=7.0 Hz, 1H, CH2), 3.18 (d,
J=8.4 Hz, 1H, CH2), 3.26 (d, J=8.8 Hz, 1H, CH2), 3.65 (m, 4H,
OCH2), 4.30 (apparent t, J=8.8 Hz, 2H, NCH), 6.70 (d, J=7.6
Hz, 2H, PhH), 6.78 (d, J=7.0 Hz, 2H, PhH), 6.88 (t, J=7.7 Hz,
2H, PhH), 7.15 (d, J=7.2 Hz, 2H, ArH), 7.18 (t, J=7.8 Hz, 2H,
PhH), 7.24-7.28 (m, 1H, ArH). 13C{1H} NMR (CDCl3, 100.6
Hz): δ 34.2, 62.1, 74.5, 105.8 (t, J=8 Hz), 112.4, 114.5, 121.7,
123.4, 125.4, 127.9, 130.1, 132.5, 141.7 (t, J=6.0 Hz), 148.9.
31P{1H} NMR (CDCl3, 161.9 Hz): δ 142.3 (s).
i
i
Hz, 7H, PrH), 1.21-1.24 (m, 14H, PrH), 2.45-2.52 (m, 2H,
CH2CHdCH2), 4.60 (q, J=5.2 Hz, 1H, CHdCH2), 4.99 (d, J=
4.4 Hz, 1H, NH), 5.10-5.16 (apparent t, 2H, CHdCH2),
5.21-5.60 (m, 1H, ArCH(NH)), 7.06 (s, 2H, (iPr)3ArH), 7.27
(d, J=8.4 Hz, 2H, ArH), 8.00 (d, J=8.4 Hz, 2H, ArH). 13C
NMR (CDCl3, 100.6 MHz): δ 9.3, 13.9, 23.8, 25.0, 27.5, 29.3,
30.0, 34.4, 42.2, 56.5, 120.7, 123.7 (d, J=19 Hz), 127.9, 132.4,
133.2, 147.4, 148.4, 150.2, 153.5. Anal. Calcd for C25H34N2O4S:
C, 65.47; H, 7.47; N, 6.11; S, 6.99. Found: C, 65.51; H, 7.55; N,
6.13; S, 7.01. The enantiomeric excess of 16a was determined by
chiral-phase HPLC (Daicel Chiracel AD, hexane/iPrOH, 9:1
(v/v), flow rate 1.0 mL/min): major enantiomer tR =9.0 min,
minor enantiomer tR=7.1 min.
N1-[1-(3-Nitrophenyl)-3-butenyl]-N,N0-dimethylsulfamoyla-
1
mide, 17a. H NMR (CDCl3, 400 MHz): δ 2.53-2.60 (m, 8H,
NMe2 þ CH2CHdCH2), 4.54 (q, J=6.0 Hz, 1H, CH=CH2),
4.81 (d, J=5.2 Hz, 1H, NH), 5.17-5.21 (m, 2H, CHdCH2), 5.63
(m, 1H, ArCH(NH)), 7.54 (t, J=7.6 Hz, 1H, ArH), 7.54 (d, J=
7.2 Hz, 1H, ArH), 8.13 (d, J=7.2 Hz, 1H, ArH), 8.20 (s, 1H,
ArH). 13C NMR (CDCl3, 100.6 MHz): δ 37.8, 42.1, 57.0, 120.5,
121.8, 122.9, 129.8, 132.6, 133.2, 144.3, 148.6. Anal. Calcd for
C12H17N3O4S: C, 48.15; H, 5.72; N, 14.04; O, 21.38; S, 10.71.
Found: C, 48.11; H, 5.77; N, 14.40; S, 10.74. The enantiomeric
excess of 17a was determined by chiral-phase HPLC (Daicel
Chiracel AS-H, hexane/iPrOH, 9:1 (v/v), flow rate 1.0 mL/min):
major enantiomer tR =23.1 min, minor enantiomer tR =26.0
min.
Spectral Data for Complex 2. 2 was obtained as an off-white
solid (0.431 g, 0.62 mmol). Yield: 62%. The single crystals were
grown by slow diffusion of hexanes into a solution of diethyl
ether. 1H NMR (CDCl3, 400 MHz): δ 3.09 (d, J=6.8 Hz, 1H,
CH2), 3.13 (d, J=7.6 Hz, 1H, CH2), 3.26 (d, J=9.2 Hz, 1H,
CH2), 3.30 (d, J=8.4 Hz, 1H, CH2), 4.34 (t, J=8.4 Hz, 2H,
NCH), 4.83-4.95 (m, 4H, OCH2), 6.77 (d, J=8 Hz, 2H, PhH),
N1-[1-(4-Nitrophenyl)-3-butenyl]-N,N0-dimethylsulfamoyla-
1
mide, 18a. H NMR (CDCl3, 400 MHz): δ 2.50-2.54 (m, 2H,
CH2CHdCH2), 2.58-2.59 (m, 6H, NMe2), 4.52 (q, J=6.8 Hz,